Wedbush Reiterates Outperform on Avanir Pharmaceuticals on Buying Opportunity Created by Short Report
UPDATE: Wedbush Initiates Epizyme at Outperform on Therapeutics Targeting HMTs
UPDATE: Webush Upgrades Ironwood Pharmaceuticals on Completed Financing
UPDATE: Wedbush Downgrades XenoPort as Arbaclofen Fails in Phase III of MS Spasticity Trial